Sanofi Looks To Climb Consumer Ladder In Boehringer Business Swap
This article was originally published in The Tan Sheet
A pending agreement includes a $5.2bn cash payment from Boehringer to Sanofi but excludes Boehringer’s consumer product business in China. The brands Sanofi will add to its consumer health lineup include two marketed in the US, Dulcolax constipation relief and Zantac heartburn remedy.
Register for our free email digests: